524711
VISTAPH
Invest Now
Start SIP in
VISTAPH
Performance
- Low
- ₹11
- High
- ₹11
- 52 Week Low
- ₹9
- 52 Week High
- ₹17
- Open Price₹11
- Previous Close₹11
- Volume2,824
Investment Returns
- Over 1 Month -3.91%
- Over 3 Month + 7.78%
- Over 6 Month -9.01%
- Over 1 Year -20.41%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -21.7
- PEG Ratio
- -0.3
- Market Cap Cr
- 67
- P/B Ratio
- 1.5
- Average True Range
- 0.73
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.17
- RSI
- 48.36
- MFI
- 61.3
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹10.80
-0.33
(-2.96%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹11.33
- 50 Day
- ₹11.13
- 100 Day
- ₹11.27
- 200 Day
- ₹11.83
Resistance and Support
11.16
- R3 11.26
- R2 11.24
- R1 11.18
- S1 11.10
- S2 11.08
- S3 11.02
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
2025-02-12 | Quarterly Results | |
2024-11-13 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-28 | Audited Results |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹10 As on 28 April, 2025 | 11:24
The Market Cap of Vista Pharmaceuticals is ₹66.5 Cr As on 28 April, 2025 | 11:24
The P/E ratio of Vista Pharmaceuticals is -21.7 As on 28 April, 2025 | 11:24
The PB ratio of Vista Pharmaceuticals is 1.5 As on 28 April, 2025 | 11:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.